Cardiologic scoring system as predictors of mortality in geriatric COVID-19 patients

Yudi Her Oktaviono1, Makhyan Jibril Al Farabi2, Aurelia Regina3

  • 1Department of Nursing Management, Universitas Airlangga, Surabaya,.

Insights

A new cardiac scoring system can predict mortality in elderly patients with coronavirus disease-2019 (COVID-19). This tool uses electrocardiograph findings to identify high-risk individuals during hospitalization.

Area of Science:

  • Cardiology
  • Geriatrics
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease-2019 (COVID-19) poses a significant mortality risk, particularly in geriatric populations.
  • Cardiac complications are frequently observed in severe COVID-19 cases, impacting prognosis.
  • Effective tools are needed to identify high-risk elderly COVID-19 patients for timely intervention.

Purpose of the Study:

  • To develop and validate a cardiologic scoring system for predicting mortality in geriatric patients diagnosed with COVID-19.
  • To identify specific electrocardiographic (ECG) findings associated with increased mortality risk in this demographic.
  • To provide a practical tool for clinicians to assess prognosis in elderly COVID-19 patients.

Main Methods:

  • Retrospective cohort study of geriatric COVID-19 patients admitted between March 2020 and April 2021.
  • Analysis of clinical data, comorbidities, ECG, and chest X-ray findings.
  • Development of a scoring system based on significant predictors identified through statistical analysis (SPSS 26).

Main Results:

  • Data from 322 geriatric COVID-19 patients (mean age 66 years) were analyzed; 17.1% died during hospitalization.
  • Five significant cardiac variables identified: cardiomegaly, sinus tachycardia, ST-segment abnormalities, pathological T-wave inversions, and axis deviation.
  • The developed scoring system demonstrated an area under the curve of 0.86, with a cut-off ≤4 offering 89% sensitivity and 69% specificity for mortality prediction.

Conclusions:

  • A novel cardiologic scoring system effectively predicts mortality in elderly COVID-19 patients.
  • The system leverages readily available cardiac findings during hospital admission.
  • This tool has the potential to improve risk stratification and patient management for geriatric COVID-19 cases.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
133
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
2.3K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
309
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
73